Cimzia subcutaneous injection 200mg syringe, manufactured by UCB Japan, contains certolizumab pegol (genetical recombination). This subcutaneous injection helps improve symptoms of rheumatoid arthritis, plaque psoriasis, psoriatic arthritis, generalized pustular psoriasis, and erythrodermic psoriasis. This 200mg 1mL per tube syringe has YJ code 3999437G1022.
Cimzia subcutaneous injection 200mg syringe
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).